These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34549828)

  • 1. Robust method for optimal treatment decision making based on survival data.
    Fang Y; Zhang B; Zhang M
    Stat Med; 2021 Dec; 40(29):6558-6576. PubMed ID: 34549828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal treatment regimes for survival endpoints using a locally-efficient doubly-robust estimator from a classification perspective.
    Bai X; Tsiatis AA; Lu W; Song R
    Lifetime Data Anal; 2017 Oct; 23(4):585-604. PubMed ID: 27480339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying optimal biomarker combinations for treatment selection through randomized controlled trials.
    Huang Y
    Clin Trials; 2015 Aug; 12(4):348-56. PubMed ID: 25948620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation in optimal treatment regimes based on mean residual lifetimes with right-censored data.
    Liu Z; Zhan Z; Lin C; Zhang B
    Biom J; 2023 Dec; 65(8):e2200340. PubMed ID: 37789592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A robust method for estimating optimal treatment regimes.
    Zhang B; Tsiatis AA; Laber EB; Davidian M
    Biometrics; 2012 Dec; 68(4):1010-8. PubMed ID: 22550953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved doubly robust estimation in learning optimal individualized treatment rules.
    Pan Y; Zhao YQ
    J Am Stat Assoc; 2021; 116(533):283-294. PubMed ID: 34024961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable selection for optimal treatment decision.
    Lu W; Zhang HH; Zeng D
    Stat Methods Med Res; 2013 Oct; 22(5):493-504. PubMed ID: 22116341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.
    Zhao YQ; Zeng D; Laber EB; Song R; Yuan M; Kosorok MR
    Biometrika; 2015 Mar; 102(1):151-168. PubMed ID: 25937641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best linear inverse probability weighted estimation for two-phase designs and missing covariate regression.
    Wang CY; Dai J
    Stat Med; 2019 Jul; 38(15):2783-2796. PubMed ID: 30908669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accountable survival contrast-learning for optimal dynamic treatment regimes.
    Choi T; Lee H; Choi S
    Sci Rep; 2023 Feb; 13(1):2250. PubMed ID: 36755137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-learning: A new classification framework to estimate optimal dynamic treatment regimes.
    Zhang B; Zhang M
    Biometrics; 2018 Sep; 74(3):891-899. PubMed ID: 29228509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the optimal treatment regimen in the presence of missing covariates.
    Huang Y; Zhou XH
    Stat Med; 2020 Feb; 39(4):353-368. PubMed ID: 31774192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On estimating optimal regime for treatment initiation time based on restricted mean residual lifetime.
    Chen X; Song R; Zhang J; Adams SA; Sun L; Lu W
    Biometrics; 2022 Dec; 78(4):1377-1389. PubMed ID: 34263933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.
    Shen J; Wang L; Daignault S; Spratt DE; Morgan TM; Taylor JMG
    J Biopharm Stat; 2018; 28(2):362-381. PubMed ID: 28934002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On Estimation of Optimal Treatment Regimes For Maximizing
    Jiang R; Lu W; Song R; Davidian M
    J R Stat Soc Series B Stat Methodol; 2017 Sep; 79(4):1165-1185. PubMed ID: 28983189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive contrast weighted learning for multi-stage multi-treatment decision-making.
    Tao Y; Wang L
    Biometrics; 2017 Mar; 73(1):145-155. PubMed ID: 27213913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.
    Orellana L; Rotnitzky A; Robins JM
    Int J Biostat; 2010; 6(2):Article 8. PubMed ID: 21969994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Step-adjusted tree-based reinforcement learning for evaluating nested dynamic treatment regimes using test-and-treat observational data.
    Tang M; Wang L; Gorin MA; Taylor JMG
    Stat Med; 2021 Nov; 40(27):6164-6177. PubMed ID: 34490942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.
    Heng F; Sun Y; Hyun S; Gilbert PB
    Lifetime Data Anal; 2020 Oct; 26(4):731-760. PubMed ID: 32274677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.